HemaVision®: Diagnostic tool for Leukemia screening

Features:

• 28 translocations screened simultaneously
• Sensitive qPCR method
• Qualitative detection
• Fast analyse time (only 4 hours)
• Simple and rapid protocol
• Tested and validated (CE-IVD marked)
• Globally used for the initial screening of patients
• Master mixes are delivered pre-aliquoted into the tubes for your qPCR instrument
• Controls included in the run – only one run per sample

HemaVision® is an aid to diagnosis meant for the initial screening.

Our customers say:

“The HemaVision® kit allows us to obtain fast results and to give important information for the diagnosis and prognosis.

“HemaVision® has easier handling through ready to use mixes, faster and more concrete results.”

“The HemaVision® workflow is reliable, robust and easy test.”

Two HemaVision® panels

DNA Diagnostic A/S produces HemaVision in two panels:
HemaVision-7Q detects 7 of the most predominant translocations.
HemaVision-28Q detects 28 translocations. Predominant once translocations, as well as many rare translocations.